Cite
HARVARD Citation
Maziarz, R. et al. (2022). Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States. Leukemia & lymphoma. 63 (9), pp. 2052-2062. [Online].